Download Sodium Hydrogen Carbonate powder Leaflet

Sodium Hydrogen Carbonate powder
This information is a summary only. It does not contain all information about
this medicine. If you would like more information about the medicine you are
taking, check with your doctor or other health care provider. No rights can be
derived from the information provided in this medicine leaflet.
Therapeutic indications
For use as an antacid for the symptomatic relief of dyspepsia.
Posology and method of administration
Adults, the elderly and children aged 12 years and over:
•
Take 1 to 5 g in water 4 to 6 hourly as required.
Not recommended for children under 12 years of age.
Contraindications
Special warnings and precautions for use
Congestive cardiac failure.
Caution should be exercised in patients who are on Sodium restricted diets and
those with cardiac disease, hypertension, renal or hepatic impairment. A
physician should be consulted if the patient is receiving other medications before
taking this product. If symptoms persist consult your doctor.
Interaction with other medicinal products and other forms of interaction
This product may cause alkalisation of plasma and urine and, as such, may affect
the renal clearance of several drugs.
Pregnancy and lactation
Data on a large number of exposed pregnancies indicate no adverse effects of
Bicarbonate of Soda (Sodium Bicarbonate BP) on pregnancy or on the health of
the foetus/newborn child. To date, no other relevant epidemiological data are
available.
Effects on ability to drive and use machines
None known.
Undesirable effects
This medicine may cause abdominal cramps and flatulence. Excessive
administration may lead to metabolic alkalosis, especially in patients with
impaired renal function.
Overdose
Excessive amounts of this medicine may cause metabolic alkalosis. Dyspepsia and
muscle weakness may occur owing to potassium depletion. Twitching tetany may
occur in hypercalcaemic patients. Severe overdosages may lead to convulsions
and coma. Treatment consists of appropriate correction of fluid and electrolyte
balance and is otherwise supportive and symptomatic. Anti-convulsant therapy
may be needed in severe overdosage.
Pharmacodynamic properties
Not applicable.
Pharmacokinetic properties
Not applicable.
Special precautions for storage
Do not store above 25°C
Lagaay International BV
Van Helmontstraat 99
3029 AA Rotterdam, The Netherlands
Tel: +31 - 10 4123871